federal health officials are expected today approve program granting long-deferred access drug azt children acquired immune deficiency syndrome announcement approval is expected be made louis sullivan secretary health human services clearance food drug administration comes years restricted access youngest victims aids only antiviral drug yet cleared treat fatal disease drug be given treatment investigational new drug status label accorded drugs believed effective lacking formal approval move make drug available free charge time children disease symptoms advanced infection adults aids have had access azt fda approved drug usage adults march more years research showing azt relieve dementia other symptoms children drug still lacks federal approval use youngest patients result many youngsters have been unable obtain drug few exceptions insurance carriers n't cover cost year so far aids has stricken children age many times number believed carry infection symptoms date children have died according federal centers disease control mothers young aids patients expressed somber satisfaction thank goodness 's happening have happened sooner said elizabeth glaser los angeles mother activist contracted aids virus blood transfusion transmitted children daughter ariel died year ago age parents unsuccessfully pleaded drug get azt says mrs. glaser bears infection symptoms daughter n't was too ill take watch child die is inhuman experience son healthy symptom-free currently takes medication delay getting azt children has been blamed combination factors traditionally medical establishment has waited years approve adult treatments pediatric uses combination conservative safety standards red tape secondly critics have charged azt maker burroughs wellcome co. corporate inertia children account just % patient population hence small part large lucrative market wellcome has replied is moving ahead compile relevant data recently promised develop pediatric syrup form easier youngsters take still comes nearly year half philip pizzo national cancer institute offered evidence azt reverse ravages aids dementia sometimes prompting dramatic recovery iq levels reappearance lost motor skills then roughly pediatric patients have received drug program mothers expected fda action is poignant reminder have been first reaction is do n't understand 's taken so long has taken people so long people understand pediatric aids is major problem asked helen kushnick son samuel died years ago age victim tainted transfusion similar sentiments were voiced capitol hill 'm pleased fda is finally releasing azt children 's taken much too long get point said rep. ted weiss did take burroughs wellcome so long apply treatment investigational new drug status new york democrat asked let not forget is same company has been profiteering drug years mr. weiss added mrs. glaser is co-founder pediatric aids foundation based santa monica calif. condemned bureaucratic corporate foot-dragging 's finger be pointed said crucial thing is learn lesson well make sure other experimental drugs bristol-myers co. ddi do n't follow same frustrating course azt aids dementia gradually steals children ability speak walk think is often most striking aspect pediatric syndrome patients azt has restored ability ride bicycle solve puzzles giving back piece childhood only temporarily 's impossible overstate much means families patients said samuel broder director national cancer institute main developer azt